Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06485661

Effect of Captopril on GLS in Duchenne Myodystrophy

Intermediate Term Effect of Captopril on Left Ventricle Global Longitudinal Strain in Patients With Duchenne Myodystrophy

Status
Recruiting
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
20 (estimated)
Sponsor
Ain Shams University · Academic / Other
Sex
Male
Age
6 Years
Healthy volunteers
Not accepted

Summary

To outline the intermediate term effect of prescribing Captopril as an add on therapy on Left ventricular functions as measured by Global longitudinal strain in patients with Duchenne myodystrophy (DMD)

Detailed description

ACEI slowing down the onset and the progression of dystrophinopathic cardiomyopathy. To outline the intermediate term effect of prescribing Captopril as an add on therapy on Left ventricular functions as measured by Global longitudinal strain in patients with Duchenne myodystrophy (DMD

Conditions

Interventions

TypeNameDescription
DRUGCaptopril TabletsPatients will be given captopril to see effect on global longitudinal strain

Timeline

Start date
2024-01-01
Primary completion
2024-09-30
Completion
2024-09-30
First posted
2024-07-03
Last updated
2024-07-16

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06485661. Inclusion in this directory is not an endorsement.

Effect of Captopril on GLS in Duchenne Myodystrophy (NCT06485661) · Clinical Trials Directory